Wednesday, October 30, 2024

2:00 PM - 5:40 PM

Room 110

---

Overview

2.00 pm - 5:40 pm: The Early-Stage Innovation Forum enables early-stage projects and technologies from research institutes, universities, hospitals and pre-series A companies in the area of human therapeutics and enabling technologies to pitch to a panel of industry experts, corporate VCs and early-stage investors to continue their commercialisation journey. 

---

Details

Expert panel: • Sarah Meibusch, Partner, OneVentures • Dr Steve Burnell, Executive Chair, Tenmile • Dr Sam South, Non-Executive Director, Reliis • Katrina Sorocos, MDHS Lead, Knowledge & Technology Transfer, The University of Melbourne Presentation 1: Centron Bio: The next generation of CNS delivery Presented by: James Tran, Centron Bio Presentation 2: A new approach to antimalarials Presented by: Eloise Keeffe, Institute for Biomedicine and Glycomics, Griffith University Presentation 3: A new therapy for Hemolytic Disease of the Newborn Presented by: Onisha Patel, Walter and Eliza Hall Institute (WEHI) Presentation 4: A novel cyanobacterial biologics system for low complexity biomanufacturing and needle-free delivery Presented by: James Brown, Bondi Bio Presentation 5: CAR-DC1: A novel next generation dendritic cell therapy for targeting solid tumours Presented by: Ewa Michalak, Walter and Eliza Hall Institute (WEHI) Presentation 6: ClearDrum - the world's first prosthetic eardrum Presented by: Philip Canner, ClearDrum Pty Ltd Presentation 7: Clinical development of brain penetrant spleen tyrosine kinase (SYK) inhibitors as potential treatments for neuroinflammation associated with neurodegenerative conditions Presented by: Tom McCarthy, Lucia Bio Pty Ltd Presentation 8: Developing first-in-class therapeutics to blunt tau pathology in tau-associated dementia such as Alzheimer's disease Presented by: Travis Stiles, Novoroo Bioscience Afternoon tea and networking break Presentation 9: NeuMessenger: mRNA gene therapy innovations for childhood dementia. Presented by: Ya Hui Hung, The Florey Institute of Neuroscience And Mental Health Presentation 10: Stellabody® Hexamer Technology: Transforming the Potency of Next-Generation Immunotherapies Presented by: Clarissa Whitehead, Burnet Institute for Medical Research and Public Health Presentation 11: The screening, optimisation and development of next-generation medicines for the treatment of key mental health disorders. Presented by: David Bibby, Pacalis Therapeutics Pty Ltd Presentation 12: Therapeutics to treat norovirus Presented by: Eloise Keeffe, Institute for Biomedicine and Glycomics, Griffith University Presentation 13: Treatment of E. coli causing Urinary Tract Infections Presented by: Luke Adams, Monash University Presentation 14: PredicTx – A digital health tool for accurate chemotherapy dosing in colorectal cancer patients Presented by: Dhiraj Hans, The University of Melbourne

---

Speaker